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Abstract
Mercury (Hg) is neurotoxic, and children may be particularly susceptible to this effect. A current
major challenge is the identification of children who may be uniquely susceptible to Hg toxicity
because of genetic disposition. We examined the hypothesis that CPOX4, a genetic variant of the
heme pathway enzyme coproporphyrinogen oxidase (CPOX) that affects susceptibility to mercury
toxicity in adults, also modifies the neurotoxic effects of Hg in children. Five hundred seven
children, 8–12 years of age at baseline, participated in a clinical trial to evaluate the
neurobehavioral effects of Hg from dental amalgam tooth fillings in children. Subjects were
evaluated at baseline and at 7 subsequent annual intervals for neurobehavioral performance and
urinary mercury levels. Following the completion of the clinical trial, genotyping assays for
CPOX4 allelic status were performed on biological samples provided by 330 of the trial
participants. Regression modeling strategies were employed to evaluate associations between
CPOX4 status, Hg exposure, and neurobehavioral test outcomes. Among girls, few significant
CPOX4-Hg interactions or independent main effects for Hg or CPOX4 were observed. In contrast,
among boys, numerous significant interaction effects between CPOX4 and Hg were observed
spanning all 5 domains of neurobehavioral performance. All underlying dose-response
associations between Hg exposure and test performance were restricted to boys with the CPOX4
variant, and all of these associations were in the expected direction where increased exposure to
Hg decreased performance. These findings are the first to demonstrate genetic susceptibility to the
adverse neurobehavioral effects of Hg exposure in children. The paucity of responses among
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same-age girls with comparable Hg exposure provides evidence of sexual dimorphism in genetic
susceptibility to the adverse neurobehavioral effects of Hg in children and adolescents.
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1. Introduction
Children are recognized as having heightened susceptibility to the adverse effects of
environmental chemicals, as compared with adults with similar exposures (Faustman et al.
2000; Landrigan and Goldman 2011). Of particular concern in this respect are possible
neurological deficits associated with mercury exposure (Clarkson 2003; Echeverria et al.
1998; Goering et al. 1992), which may cause impairment of the developing central nervous
system along with attendant personality, cognitive function and behavioral disorders
(Counter and Buchanan 2004; Davidson et al. 2004; Levy et al. 2004). A current major
challenge is the identification of those children who may be uniquely susceptible to Hg-
mediated neurological deficits because of genetic predisposition.
Previous studies in adults have identified at least 4 commonly expressed genetic
polymorphisms that modify the effects of Hg on a wide range of neurobehavioral functions
(Echeverria et al. 2005, 2006, 2010; Heyer et al. 2004, 2008, 2009). Of particular interest in
this respect is a single nucleotide polymorphism (A>C) (rs1131857) in exon 4 of the gene
encoding an asparagine-to-histidine change at amino acid 272 (N272H) of the heme
biosynthetic pathway enzyme, coproporphyrinogen oxidase (CPOX, EC 1.3.3.3). This
variant, referred to herein as “CPOX4”, both increases sensitivity to the neurobehavioral
effects of Hg (Echeverria et al. 2006) and modifies urinary porphyrin excretion as a potential
biomarker of this effect (Woods et al. 2005; Li and Woods 2009). The population
frequencies of the homozygous wildtype (A/A), heterozygous (A/C) and homozygous
mutant (C/C) genotypes within this cohort were 0.72, 0.25, and 0.03, respectively, and were
equally prevalent among males and females, suggesting substantial exposure to the CPOX4
variant.
In the present study, we examined the hypothesis that CPOX4 would modify the adverse
neurobehavioral effects of Hg exposure in children as previously observed in adults.
Subjects were children and adolescents who participated in a recently completed prospective
randomized dental amalgam clinical trial between ages 8–18 and for whom longitudinal
(annual) neurobehavioral assessments and quantitative measures of dental amalgam Hg
exposure over 7 years of follow-up were available. Additionally, to preclude selection bias
possibly associated with those genotyped for CPOX4 per se, we made comparable
assessments with respect to second single nucleotide polymorphism located at exon 5
(rs1729995) (G>A) of the CPOX gene encoding a synonymous mutation in the CPOX
enzyme (E330E), referred to herein as “CPOX5”. CPOX5 has been previously identified as
distributed among men and women within our adult dental population with frequencies of
the homozygous common (wildtype), heterozygous, and homozygous mutant alleles of 0.48,
0.43 and 0.09, respectively (Woods et al., 2005). CPOX5 is not known to be in linkage
disequilibrium with CPOX4. We made these assessments independently in boys and girls.
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2. Methods
2.1. The Study Population
The current study was performed on a subset of 330 subjects who participated as children in
the Casa Pia Dental Amalgam Clinical Trial (DeRouen et al. 2002; 2006) conducted
between 1996 and 2006. Participants in the clinical trial included 279 boys and 228 girls,
aged 8–12 yrs at baseline, who were students of the Casa Pia school system in Lisbon,
Portugal. Children were initially randomized to Hg amalgam (treatment) or composite resin
(control) dental treatment groups. Subjects were evaluated at baseline and at 7 subsequent
annual intervals following initial dental treatment using an extensive battery of
neurobehavioral assessments (Slade et al. 2008; Townes et al. 2008a, 2008b). Follow-up
data were obtained on a similar number of subjects in each treatment group. Studies
conducted during the course of the clinical trial (Evens et al. 2001) demonstrated that the
children had no significant exposure to methylmercury from dietary fish consumption.
However, other unidentified sources of environmental mercury exposure may have
contributed to baseline urinary mercury concentrations, which were 1.5 ± 1.2 (0.1–7.7) and
1.4 ± 1.1 (0.0–8.6) µg/L for amalgam and composite groups, respectively. Mean urinary
mercury concentrations by treatment group and by gender for each year of the clinical trial
have been previously published (Woods et al. 2007).
2.2. Neurobehavioral tests employed
A comprehensive neurobehavioral test battery was used in this analysis, including measures
from the Rays Verbal Learning Test (RAVALT), subtests from the Wide Range Assessment
of Memory and Learning and Visual Motor Abilities (WRAVMA), the Wechsler
Intelligence Scale for Children III (WISC-III), and the Wechsler Intelligence Scale for
Adults-III (WMS-III), Simple Reaction Time, Finger tapping, Trailmaking A and B, the
Stroop test, and Wisconsin Card Sort. The validity and rationale underlying the use of these
tests in the clinical trial have been described (Martins et al. 2005).
Table 1 lists the 23 neurobehavioral tests that were assessed and presents their means and
standard deviations at their last year of administration (Year 7). Tests are organized within
the behavioral domains that were evaluated in the clinical trial (DeRouen et al., 2006).
Arrows depict whether the test score increases or decreases in magnitude with improved
performance. Diminished or adversely affected performance associated with Hg exposure or
CPOX4 variant status is described as occurring in the direction of impaired performance,
whereas enhanced or beneficially affected performance associated with either of these
variables is described as occurring in the direction of improved performance. The
Comprehensive Test Of Nonverbal Intelligence (CTONI) was given to each child at the
beginning of the clinical trial to obtain a measure of IQ at baseline.
2.2. Genotyping assays
Genotyping for the present study was performed on DNA extracted from buccal cell samples
that were obtained from study subjects following completion of the clinical trial (n=199) or
from blood samples that were obtained at baseline for blood lead assessments (n=152).
Genotyping was performed by the Functional Genomics Laboratory of the NIEHS Center
for Ecogenetics and Environmental Health at the University of Washington, using
automated DNA sequencing assays. Oligonucleotides used for PCR and sequencing as well
as primer and allele-specific probes used for fluorescent 5'-nuclease assays have been
previously described in detail (Woods et al. 2005). In the present study, each child was
evaluated for CPOX4 gene status, and categorized as CPOX wild type (A/A) or CPOX4 (A/
C or C/C) if either a single or double allelic variant, respectively, was found. Children were
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also characterized for the CPOX5 variant as CPOX wildtype (G/G) or CPOX5 (G/A or A/A)
if either a single or double allelic variant, respectively, was found.
2.3. Human subjects considerations
All parents or guardians of children who participated in the clinical trial gave written
consent, and all children provided signed assent, for the treatments and assessments made
during the course of the trial, including collection of blood samples. Written consent was
also obtained from all participants who provided buccal cell samples for genotyping
subsequent to completion of the clinical trial. The study protocols for both the clinical trial
and the present genotyping study were approved by the institutional review boards at the
University of Lisbon and the University of Washington.
2.4. Urinary mercury analysis
A urine sample (~50 ml) was collected from each child at baseline of the clinical trial and at
each subsequently scheduled annual visit to the University of Lisbon School of Dental
Medicine for dental, neurologic, and neurobehavioral evaluations. Analysis of total mercury
(Hg) was performed by continuous flow, cold vapor spectrofluorometry, as previously
described (Pingree et al. 2001). Urinary creatinine concentrations were measured using a
standard colorimetric procedure (Sigma #555-A; Sigma-Aldrich, St. Louis, MO, USA).
Urinary Hg concentrations were calculated as micrograms per gram creatinine (µg/g
creatinine). Urinary Hg concentrations were transformed into natural logs after adding one
[ln(HgU+1)] and used in this form as a quantitative measure of Hg exposure for all
statistical analyses.
2.5. Statistical Analyses
This study evaluated whether CPOX4 or CPOX5 gene status affected the relationship
between Hg exposure and tests of neurobehavioral functions among children who were
evaluated annually from baseline through 7 years of follow-up after initial placement of
dental amalgam (Hg) or composite resin tooth fillings (DeRouen et al. 2006).
Urinary Hg concentrations (HgU) measured at each annual behavioral test session were
employed as the measure of Hg exposure instead of the dichotomous assignment to
amalgam or composite resin treatment groups as performed in the clinical trial. Treatment
assignment from the clinical trial was evenly split among boys (81 from the composite
group and 83 from the amalgam group), whereas girls came slightly more frequently from
the amalgam group (74 composite and 92 amalgam). However, treatment assignment
accounted, at most, for only 17% of the variation in HgU among boys (Year 2 r2=0.171) and
15% among girls (Year 2 r2=0.154).
Statistical analyses were performed using SPSS Version 19 (IBM®SPSS®, Chicago, IL,
USA). The wide range in ages of subjects at the beginning of the clinical trial (8–12 years)
and the changing of specific tests administered to various age groups during the course of
the trial, e.g., child versus adult versions of some tests, militated against the propitious use
of repeated measures analysis. Therefore, we employed concurrent urinary Hg
concentrations (HgU) and neurobehavioral test performance data acquired from the second
year of follow-up (Year 2, where mean HgU reached a peak among both boys and girls in
the cohort) to estimate the acute effects of Hg exposure on performance, and both maximum
and cumulative measures of HgU over the entire study period as well as performance
outcomes during the last year of the study (Year 7) to evaluate chronic effects of Hg
exposure.
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Acute measures of Hg exposure were calculated as the natural log of HgU adjusted by 1
(ln[HgU+1]). The natural log best accommodates how exposures are distributed
biologically, whereas adding 1 minimizes the influence of very small changes in HgU at
very low levels (which could have otherwise dominated the analyses). Maximum HgU was
simply the largest value of this acute measure across all study years. Cumulative HgU was
calculated as the natural log of the sum of all HgU with 1 added to this summation
(ln[(ΣHgU)+1]).
Because the effect of the CPOX4 variant on neurobehavioral performance as affected by Hg
exposure was the principal focus of this study, we developed an analytical protocol
reflecting this focus. As a first step, we used a base model that included the measure of Hg
exposure (as defined above), CPOX allelic status (dichotomous as either wildtype or het/mut
for CPOX4), and their interaction term. In addition, this model included the covariates of
age at assessment, race, and non-verbal IQ (determined at baseline). Performances on
neurobehavioral tests were each individually evaluated as the outcome variable in separate
analyses for boys and girls.
Step two was initiated whenever there was a significant interaction term between Hg
exposure and CPOX allelic status. This finding was taken as evidence of effect modification,
and thus analyses of effect between Hg exposure and test performance were calculated
separately among boys or girls genotyped as either CPOX wildtype or CPOX4 variant
status. This strategy provided a clear description of Hg dose-response relationships within
each genotypic group.
Step three involved evaluating main effects when the interaction term between Hg exposure
and CPOX allelic status when genotyped for CPOX4, was not significant. In this case, the
interaction term was dropped from the baseline model, and the main effects of Hg exposure
and CPOX status were evaluated among the full cohort of boys or girls.
This analytical approach was repeated for children genotyped for CPOX5 allelic status.
Prior to fitting the regression models, we examined the assumptions of the model by
scrutinizing the distributions and variances of all cognitive tests and ln(Hg). Most
distributions had no significant deviation from normality or inflated variance. After fitting
each model, we examined the standardized residuals for statistical outliers. In the rare event
that an outlier was found, it was removed and the model was refit.
3. Results
The study cohort consisted of 330 children (164 boys and 166 girls) for whom CPOX4 or
CPOX5 gene status was available from among 507 total subjects enrolled at the start of the
clinical trial. Excluded subjects either did not provide a blood sample at the initiation of the
study, or were lost to follow-up for acquisition of a buccal cell sample following completion
of the trial. Table 2 presents the characteristics of the cohort at Entry as well as at Years 2
and 7 of the clinical trial. Both boys and girls averaged 10.1 years of age, and most were in
the 4th grade at entry into the study. Approximately 74% of boys and 71% girls were
Caucasian at Entry, and each had an average non-verbal IQ score of 86. Table 2 also
displays the mean “Raw” values for urinary Hg concentrations (HgU) and the natural log
calculations for the HgU at Entry, Year 2 and Year 7 of the clinical trial, as well as the
calculated maximum and cumulative values for both sexes at Year 7. Minimum and
maximum urinary mercury concentrations for each entry are also presented. The change in
number of total subjects between Entry and Year 7 reflects the overall 14% loss to follow-up
over the course of the clinical trial (DeRouen et al. 2006). The frequencies of the
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homozygous common (wildtype), heterozygous, and homozygous mutant alleles for boys
and girls for CPOX4 and CPOX5 are also presented.
3.1. CPOX4 Analyses: Effects on Acute Hg Exposure
Results of analyses of modification by the CPOX4 variant on neurobehavioral test outcomes
associated with acute Hg exposure (based on HgU at Year 2) are presented in Table 3.
Among boys, significant interaction effects between CPOX4 and Hg exposure were
observed for 3 of the 23 tests of neurobehavioral function evaluated during the clinical trial.
These included the Stroop color and word/color tests, both within the Attention domain, and
dominant hand finger tapping, a test of Motor function. The significant dose-response
relationships between performance and acute Hg exposure for these tests were all in the
expected (adverse) direction and were restricted to boys with the CPOX4 variant. There
were no main effects observed for any of the other tests.
Among girls, CPOX4 significantly modified the effects of acute Hg exposure on only 2 tests
of neurobehavioral function, the RAVALT Trial 5 and Trail 8-List 20', both within the
Learning and Memory domain (Table 3). In both cases, significantly impaired performance
associated with acute Hg exposure was observed only among girls with the CPOX4 variant.
Also among girls, 4 tests were observed to have significant main effects associated with
acute Hg exposure (not shown). Among these, only the Trails A test (p ≤ 0.03) was in the
impaired direction, while 3 tests, Stroop Color/Word (p ≤ 0.03), RAVALT Trial 6 (p ≤ 0.02)
and the Peg test for the dominant hand (p ≤ 0.03), had significant associations in the
direction of improved performance. In addition, 2 tests, finger tapping dominant (p ≤ 0.001)
and non-dominant (p ≤ 0.01), had significantly improved performance among girls identified
as having the CPOX4 variant. Aside from Motor function, no domain of neurobehavioral
function was found to have more than 1 test that achieved statistical significance in terms of
either main effect of acute Hg exposure or CPOX4 gene status among girls. Therefore, no
domain could be said to be predominantly affected by acute Hg exposure or CPOX4 variant
status among girls.
3.2. CPOX4 Analyses: Effects on Chronic Hg Exposure among Boys
In contrast to effects with acute Hg exposure, analysis of the effects of CPOX4 on
neurobehavioral performance associated with chronic Hg exposure among boys showed
numerous significant interaction terms across a wide range of tests and performance
domains (Attention, Visual-Spatial, Executive Function, Learning & Memory, and Motor).
These results are presented in Table 4. When cumulative exposure was used as the chronic
Hg exposure measure, significant Hg dose-response effects were observed on 11 of 23
neurobehavioral test outcomes among boys with the CPOX4 variant, all in the impaired
direction, with 7 associations being significant at p ≤ 0.01. In contrast, no significant
cumulative Hg dose-response effects on neurobehavioral test performance were observed
among boys genotyped as CPOX wildtype.
Using maximum exposure as the chronic Hg exposure matrix, 14 tests demonstrated
significant dose-response relationships among boys with CPOX4 variant status, 12 being
significant at p ≤ 0.01. The 15th test (WRAVMA Pegs Non-Dominant) reached near
significance (p ≤ 0.06). All of these effects are significantly adversely affected in relation to
Hg exposure among boys with CPOX4 variant status. In contrast, among boys genotyped as
CPOX wildtype, only 1 neurobehavioral function (Finger tapping-Dominant) was
significantly associated with maximum Hg exposure (p ≤ 0.03), and this was in the direction
of improved performance (Table 4).
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Table 5 presents the significant main effect relationships for tests of neurobehavioral
performance for which significant interaction terms were not observed among boys in the
present analyses. When evaluated in terms of the cumulative chronic Hg exposure matrix, 4
tests of neurobehavioral performance were significantly associated with Hg exposure and 1
specifically with CPOX4 gene status. While all of these associations were in the direction of
impaired performance, most were of only borderline significance in terms of suggesting
independent effects of either chronic Hg exposure or CPOX4 gene status on neurobehavioral
performance. When evaluated in terms of the maximum chronic Hg exposure matrix, 3 test
outcomes were found to be significantly associated with Hg exposure, but none specifically
with the CPOX4 variant.
3.3. CPOX4 Analyses: Effects on Chronic Hg Exposure among Girls
In contrast to findings among boys, no significant dose-response relationships for Hg
exposure were observed for either maximum or cumulative chronic Hg exposure measures
when evaluated separately among CPOX wildtype or CPOX4 variant girls, despite the fact
that 2 tests (WAIS-III Digit Span and RAVLT Trial 6 – List B) had significant interaction
terms between CPOX4 and maximum chronic exposure. Main effects analyses among all
girls found no significant associations with either measure of chronic Hg exposure.
However, 2 tests (finger tapping dominant and simple reaction time) had significant (p ≤
0.01 or p ≤ 0.02) associations with CPOX4 for both chronic Hg measures. Three of these 4
associations showed significantly improved performance among girls identified as having
the CPOX4 variant versus those with CPOX wildtype.
3.4 Analyses of CPOX4 Effects by Neurobehavioral Domain
3.4.1 Attention—The Attention domain includes 3 Stroop subtests, the Digit and Spatial
Span tests (considered to be more related to Attention and rehearsal than to Memory), and
the Trails A test. One of the Stroop tests, the Color/Word test, introduces discordance
between the color spelled out and the color in which the word is written. This test requires
what may be called “directed attention”, in that it includes areas of brain function other than
those specifically associated with attention, and thus is not as direct a measure of simple
attention as the other tests.
Among the CPOX4 acute effects analyses (Table 3), 2 of the Stroop subtests (Color and
Color/Word) had significant dose-response associations among boys with the CPOX4 gene
variant. The CPOX4 chronic effects analyses (Table 4) involved all of the Attention Domain
tests except for the Stroop Color/Word sub-test. These analyses suggest that Attention is
highly impacted by Hg among boys with CPOX4 variant status when evaluated in terms of
either maximum or cumulative Hg exposure.
3.4.2. Visual-Spatial Acuity—The Visual-Spatial domain tests include Simple Reaction
Time (responding to a visual stimulus), Digit Symbol (coding a symbol with a digit), and
Symbol Search (scanning to find a target symbols). As shown in Table 4, significant
associations for tests of Visual-Spatial acuity were found for analyses employing measures
of chronic but not acute Hg exposure among boys. Two tests, Simple Reaction Time and
Digit Symbol, had significant dose-response associations with both maximum and
cumulative chronic exposure matrices among boys genotyped as having CPOX4 variant but
not CPOX wildtype status. Additionally, in the main effects analyses (Table 5), the Symbol
Search test had significant associations with both chronic Hg exposure matrices. These
analyses show that the Visual-Spatial domain can be impacted by Hg exposures within this
genetic subgroup.
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3.4.3. Executive Function—Executive Function tests included Wisconsin Card Sort
(sorting cards by changing criteria) and Adult Trails B (following a trail of alternating
numbers and alphabet letters). As shown in Table 4, CPOX4 was found to significantly
modify the effect of Hg exposure on only the latter test of Executive Function among boys,
and this effect was restricted to the analysis employing the maximum exposure matrix as a
measure of chronic Hg exposure. This effect, however, was in the direction of impaired
performance and the association was highly significant (p ≤ 0.003)
3.4.4. Learning & Memory—The Learning & Memory domain included 9 measures
consisting of 5 sub-tests of the RAVLT (an auditory verbal learning test using a list of 15
words with distraction and delayed recall), 2 Visual Reproductions tests (redrawing a figure
immediately and delayed), and the CVMT test (recalling which visual objects are repeated).
Among the analyses assessing the effects of CPOX4 variant status on acute Hg exposure
effects (Table 3), CPOX4 was found to significantly modify the adverse effects of acute Hg
exposure on 2 of the RAVALT sub-tests (Trails 5 and Trials 8 – list A 20') among girls,
constituting the principal positive observation regarding the interaction of CPOX4 and Hg
exposure among girls in this study. No associations of gene status with indices of chronic
Hg exposure among girls were observed.
In contrast, 3 RAVALT sub-tests were found to have significant dose-response associations
with the maximum Hg chronic exposure matrix among boys with the CPOX4 variant (Table
4), and 1 also having a significant association with the cumulative Hg exposure matrix. In
the main effects analyses (Table 5), both immediate and delayed Visual Reproductions tests
were found to have significant independent associations with both chronic Hg exposure
matrices.
3.4.5. Motor Function—The Motor function domain tests include Finger Tapping
(number of taps in a fixed time) and the Pegs test (number of dowels inserted into a hole in a
fixed time). Both tests evaluate dominant and non-dominant hand performance separately.
All 4 of these tests either approached significance or were significantly associated with the
maximum exposure matrix among boys carrying the CPOX4 variant, with 1 association in
the direction of improved performance among boys genotyped as CPOX wildtype (Table 4).
There were 3 tests (excluding Peg dominant hand) related to the cumulative Hg exposure
matrix among boys with the CPOX4 variant. Whereas most of the associations observed in
this domain demonstrated only moderate significance levels, the interaction of CPOX4 and
Hg exposure on the Finger Tapping non-dominant hand test was highly significant.
3.5. CPOX5 Analyses
No significant interaction effects were observed for CPOX5 and any measure of Hg
exposure among either boys or girls. Moreover, no main effects were observed for CPOX5.
3.6. Summary of Results
CPOX4 gene status was found to modify the adverse effects of chronic Hg exposure on a
wide range of neurobehavioral performance test results among boys. All of these effects
were in the direction of impaired performance and spanned all 5 neurobehavioral domains.
Many of the observed associations were highly significant (p ≤ 0.01). These highly
consistent observed associations, affecting more than half the neurobehavioral tests
evaluated, cannot be dismissed due to the large numbers of tests and exposures evaluated. If
we assume that the outcomes for each of the 23 tests evaluated were totally independent of
each other, the binomial probabilities of our findings for the two chronic measures would be
<2×10−12 for cumulative exposure and <2×10−17 for maximum exposures. While there
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clearly are strong correlations between performances on various behavioral tests, the
consistency of these results is nonetheless highly compelling.
Finally, the converse lack of associations between Hg exposure and CPOX wildtype status
suggests that the CPOX4 variant may be important in mediating neurotoxic effects of Hg
exposure in boys. The absence of associations when comparable analyses were conducted
for the CPOX5 variant argues against these observations being due to some selection
process.
Discussion
Numerous studies have proposed a component of genetic susceptibility to neurobehavioral
disorders associated with mercury and other xenobiotic exposures (Braun et al. 2006;
Gundacker et al. 2010; Engström et al. 2008; Suk and Collman 1998), although the
modifying effects of commonly expressed genetic variants on these associations are just
beginning to be defined. This is the first study, to our knowledge, to describe a genetic
polymorphism that modifies the effects of mercury exposure on a wide variety of
neurobehavioral functions in children. Previous studies provided evidence of significant
associations between Hg exposure and the CPOX4 variant on neurobehavioral functions in
adult dental professionals (Echeverria et al. 2006), although observed joint effects in that
study were found to be strictly additive in nature. The present findings of synergistic, i.e.,
more than additive, interactions between Hg and CPOX4 on numerous neurobehavioral
functions are consistent with potentially heightened susceptibility of children to the adverse
neurobehavioral effects of Hg specifically associated with the CPOX4 genetic variant.
The paucity of findings of independent effects of Hg exposure on tests of neurobehavioral
function in this study provide some consistency with findings from the dental amalgam
clinical trial (DeRouen et al. 2006), in which exposure to Hg from dental amalgam was
found not to be associated with deficits in any tests of neurobehavioral performance among
either boys or girls. However, when controlling for CPOX gene status as performed here, Hg
exposure was strongly associated with diminished performance across a wide range of the
same tests, among boys with the CPOX4 variant. Diminished performance was most
predominantly observed in tests of Attention, suggesting possible impairment of attentional
vitality and flexibility, e.g., ability to sustain attention or to shift between 2 sequences held
in working memory (Echeverria et al., 2002). Significant interactions between Hg exposure
and CPOX4 on tests of Learning & Memory and of Visual-Spatial acuity were also
observed, suggesting possible decrements of verbal learning and memory as well as of
perceptual cognition. Effects on tests of Motor function, including measures of manual
coordination and fine motor speed, also appear to be adversely affected when evaluated
within the context of chronic Hg exposure among boys with the CPOX4 variant. These
findings have important public health implications, inasmuch as mean urinary mercury
levels among boys in this study ranged from 1.4 (1.3–1.6) µg/g creatinine at baseline to a
maximum of 2.2 (1.8–2.5) µg/g creatinine at Year 2 of follow-up in the dental amalgam
clinical trial. By comparison, geometric mean urinary mercury levels measured among a
nationally representative sample of children 12–19 years of age acquired as part of the
2003–2004 U.S. National Health and Nutrition Examination Survey (Centers for Disease
Control and Prevention 2007) were 0.358 (0.313–0.408) µg/g creatinine. Although this value
is substantially lower than those measured in the present study, the mean urinary Hg
concentration in the 90th percentile of that sample was 1.59 (1.13–2.52) µg/g creatinine,
comparable to the range of Hg concentrations at which adverse neurologic effects of Hg
were observed herein among boys with CPOX4. These observations suggest potential
adverse neurobehavioral effects of Hg among boys with the CPOX4 variant who fall within
the top 10% of subjects sampled within that survey for Hg exposure.
Woods et al. Page 9
Neurotoxicol Teratol. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The mechanistic association of CPOX4 to neurobehavioral functions remains to be
delineated, although potential alterations in physiological heme availability and/or heme-
dependent processes associated with diminished CPOX4 activity may underlie this effect (Li
and Woods, 2009). In this regard, heme is known to play a critical role as a signaling
molecule in glutaminergic neuronal receptor processing and synapse development
(Chernova et al. 2006; Sengupta et al. 2005), as well as in the regulation of serotonin (5-
hydroxytryptamine) synthesis and signaling in the central nervous system (Litman and
Correia 1983, 1985). Disorders of both systems have been implicated as etiologic in a
variety of neurodevelopmental and neurobehavioral disorders (Chernova et al. 2011;
Chugani et al. 1999; Smith et al. 2012), and both could be amenable to disruption by heme
deficiency during critical periods of neurological development in children, particularly in
association with mercury exposure (Li and Woods 2009). While these observations provide
a scientific rationale for the diminished neurobehavioral performance observed here among
boys with the CPOX4 variant and Hg exposure, further studies are required to define the
specific mechanistic events underlying this association.
The absence of effects of CPOX5 on neurobehavioral functions when evaluated in relation
to any measure of Hg0 exposure in this study suggests that the CPOX4 variant may act in a
genotype-selective manner to mediate the adverse neurobehavioral effects of Hg exposure
observed here. While the potential effects of CPOX5 on CPOX enzymatic activity, heme
bioavailability, or processes affecting neurological function are not known, CPOX5 need not
be viewed as incapable of affecting biological processes, inasmuch as synonymous SNPs are
widely recognized as mediating changes in translation kinetics, protein folding and other
factors that underlie a wide variety of neurological and other disorders in humans (Chamary
et al. 2006; Duan et al. 2003; Komar 2007). Moreover, the heterozygous and full mutant
variants of CPOX5 were distributed quite differentially from those of CPOX4 within this
cohort, only 7 subjects (2%) sharing both CPOX4 and CPOX5 variant status, militating
against selection bias in terms of findings observed with respect to those with CPOX4.
Further research analyzing multiple SNPs within the CPOX gene as well as others
associated with heme-dependent neurotransmitter processing pathways is required to
identify the mechanisms underlying the apparent selective effects of CPOX4 seen here.
Notable differences between boys and girls in the effects of Hg exposure and the CPOX4
variant on neurobehavioral test performance were observed in this study. Although Hg
exposure from dental amalgam was comparable among boys and girls participating in the
clinical trial (DeRouen et al, 2006), sex-related differences in Hg toxicokinetics that may
afford greater Hg excretion and, consequently, lesser likelihood of Hg retention and
accumulation in girls than boys may contribute to this effect (Woods et al. 2007). Numerous
other factors that include genetic and hormonal differences affecting brain development,
structure and function between boys and girls are also likely to contribute to the gender
differences observed here (Gochfeld 2007; Hines et al. 2010; Vahter et al. 2007a,b;
Valentino et al. 2012). Differences in detection sensitivity for CPOX4 between boys and
girls in this study have a less clear explanation, although genetic factors underlying gender
differences in numerous psychiatric and neurobehavioral disorders have been reported
(Baca-Garcia et al. 2002; Gaub and Carlson 1997; Harrison and Tunbridge 2008;
Samochowiec et al. 2004). The observation that neither Hg exposure nor CPOX4 alone
substantially affected neurobehavioral performance in girls suggests that sex-related
predisposition, in addition to differences in Hg toxicokinetics, affects susceptibility. Of note,
measures of cognitive function and other behaviors not specifically related to reproduction
are often sex-linked, accounting for substantial differences in response to many chemical
agents, with subsequent expression in behavior (Weiss 2002). In this respect, many classes
of chemicals including dioxins and polychlorinated biphenyls (Weiss 2002), metals (nickel
arsenic, lead, cadmium, mercury) (Vahter et al. 2007a,b), pesticides (paraquat,
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dithiocarbamate, triazole fungicides) (Vahter et al. 2007a), cigarette smoke (Kelada et al
2002); and various classes of drugs (Calabrese 1985) are reported to differentially affect
neurologic functions in males and females, both in humans and animal models (Vahter et al.
2007a; Bjorklund et al., 2007; Gochfeld 2007). The sexually divergent responses to Hg
exposure and genetic disposition observed in the present study highlight the importance of
considering such differences in development of strategies aimed at risk assessment and
prevention, especially in children.
In conclusion, the present studies demonstrate significant adverse effects on neurobehavioral
functions associated with chronic Hg exposure and the CPOX4 genetic variant among
children, with effects manifested predominantly among boys. These findings are the first to
describe a genetic polymorphism that modifies the effects of Hg exposure on
neurobehavioral functions in children, and suggest directions for future research to define
mechanisms underlying differential sensitivity to mercury between boys and girls.
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Highlights
• CPOX4, a SNP of coproporphyrinogen oxidase, enhances Hg neurotoxicity in
children.
• Interactions of CPOX4 and Hg span all 5 domains of behavioral performance.
• Modification of Hg neurotoxicity by CPOX4 is restricted largely to boys.
• Sexually dimorphic genetic susceptibility to Hg toxicity in children is apparent.
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Table 1
Neurobehavioral tests assessed with mean scores for Year 7 (Final year of clinical trial)
Test / Domain Measurea Boys N = 121
Mean (SD)
Girls N = 118
Mean (SD)
Attention
Stroop Test – Color, # correct ↑ 66.41 (11.96) 69.23 (10.43)
      Word # correct ↑ 90.07 (15.18) 91.47 (15.23)
      Color-Word # correct ↑ 41.84 (9.78) 43.88 (8.75)
WAIS-III – Digit Span # correct ↑ 14.34 (3.68) 14.14 (2.77)
WMS III – Spatial Span # correct ↑ 15.84 (3.02) 15.58 (3.12)
Adult Trails A Time (sec) ↓ 26.35 (10.62) 30.38 (11.38)
Visual-Spatial
Simple Reaction Time Time (sec) ↓ 0.74 (0.15) 0.77 (0.13)
WAIS III – Digit Symbol # correct ↑ 72.45 (17.09) 76.68 (13.87)
    Symbol Search # correct ↑ 33.15 (8.85) 34.57 (8.04)
Executive Functioning
Wisconsin Card Sort – Categories Completed # categories ↑ 3.06 (1.38) 3.08 (1.47)
Adult Trails B Time (sec) ↓ 65.69 (26.99) 63.41 (23.67)
Learning & Memory
RAVALT Tr1 – List A # correct ↑ 5.61 (1.49) 6.10 (1.86)
    Tr5 – List A # correct ↑ 11.24 (2.20) 11.54 (2.23)
    Tr6 – List B # correct ↑ 4.73 (1.38) 5.27 (1.56)
    Tr7 – List A/Post B # correct ↑ 9.85 (2.56) 10.22 (2.48)
    Tr8 – List A after 20’ # correct ↑ 9.30 (2.72) 10.07 (2.77)
WMS-III – Visual Reproductions – Immediate # correct ↑ 34.72 (4.65) 36.61 (2.98)
      Delayed # correct ↑ 31.98 (6.96) 34.90 (4.02)
CVMT d-Prime Score ↑ 1.51 (.94) 1.61 (.88)
Motor
WRAVMA –Pegs – Dominant # Pegs ↑ 47.40 (8.50) 49.92 (6.30)
      Non Dominant # Pegs ↑ 44.33 (7.57) 45.02 (6.12)
Finger Tapping - Dominant # Taps ↑ 52.75 (5.59) 48.44 (5.72)
      Non Dominant # Taps ↑ 46.66 (5.90) 42.53 (5.81)
aArrows show direction of improved performance.
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Table 3
Acute Hg dose-response effects among boys and girls with CPOX WT or CPOX4 variant in Year 2
Measure
WT Het or Mut
Beta (SE) rpart (p) Beta (SE) rpart (p)
BOYS
Attention Domain
Stroop Test – Color −.19 (1.80) −01 (.92) −8.40 (2.80) −.42 (.005)
Stroop Test – Word/Color 1.09 (1.51) .07 (.47) −3.50 (1.68) −.31 (.04)
Motor Domain
Finger Tapping - Dominant 1.21 (.91) .13 (.19) −3.25 (1.53) −.32 (.04)
GIRLS
Learning and Memory Domain
RAVALT TR 5 .28 (.43) .07 (.51) −1.34 (.47) −.38 (.006)
RAVALT TR 8 - List A 20' .34 (.45) .08 (.46) −1.69 (.55) −.40 (.003)
Values in bold signify p ≤ 0.05.
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